Chondrial Therapeutics

Chondrial Therapeutics

Latest funding
$22,600,000
Venture capital (Series A) - 2017
Deerfield Capital Management
Team Size
1–10
Employees
$22,600,000 Venture capital (Series A)
FinSMEs

Chondrial Therapeutics Secures up to $22.6M in Series A Financing